Tvardi Therapeutics paid its 6 named executives $10.2M in total in FY2025 (Dec). CEO Imran Alibhai, Ph.D. was paid $3.1M of that.
Pay$100 in the stock at the end of FY23 → $16
Pay of each named executive
Imran Alibhai, Ph.D.Chief Executive Officer and Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Christopher PosnerFormer (Cara) President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
John Kauh, M.D.Chief Medical Officer
| FY2025 (Dec) |
1 year
Dan Conn, J.D., M.B.A.Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Ryan MaynardFormer (Cara) Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
3 years
Scott TerrillionFormer (Cara) General Counsel, Secretary and Chief Compliance Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.